Results 111 to 120 of about 9,079 (162)

Vector-directed immunity and boosting capacity of VRP-srRNA anti-tumor vaccines. [PDF]

NPJ Vaccines
Ma X, Marek RD, Gammell S, Summers AN, Wang T, Liu CX, Lei G, Wei J, Crosby EJ, Hobeika A, Lyerly HK, Morse MA, Hartman ZC.   +12 more
europepmc   +1 more source

Coronavirus genome packaging and nucleocapsid assembly. [PDF]

J Virol
Masters PS.
europepmc   +1 more source

Trans-complementation of chikungunya virus replicase mutants reveals alphavirus replication complexity and supports antiviral tool development. [PDF]

PLoS Pathog
Wang S, Naumenko K, Mirzajani Sarvandani M, Lello LS, Makhotina A, Claesson HC, Žusinaite E, Merits A.   +7 more
europepmc   +1 more source

Molecular mechanisms of protease precursor autoprocessing of RNA viruses: a comprehensive review. [PDF]

Virol J
Mótyán JA, Golda M, Mahdi M, Nashed NT, Louis JM, Tőzsér J.   +5 more
europepmc   +1 more source

Reprogramming of lipid metabolism by ORF3a-induced microlipophagy enhances biogenesis of SARS-CoV-2 replication organelle. [PDF]

PLoS Pathog
Li Z, Hui X, Zheng M, He Z, Huai W, Ding B, Jin M, Qin Y, Chen M.   +8 more
europepmc   +1 more source

Chikungunya in 2025: Comprehensive Insights into Virology, Diagnostics, Vaccines, and Antiviral Therapies. [PDF]

Viruses
Zheng Z, Ji H, Shan Z, Xu J, Li J, Zhang X, Zheng J, Jiang S, Zhang N.   +8 more
europepmc   +1 more source

Minimal Polymerase-Containing Precursor Required for Chikungunya Virus RNA Synthesis. [PDF]

Viruses
Aponte-Diaz D, Jain A, Harris JM, Arnold JJ, Cameron CE.   +4 more
europepmc   +1 more source

Behind the membranous curtain-lipid dynamics and functions in coronaviral replication. [PDF]

J Virol
Salisch F, Müller-Ruttloff C.
europepmc   +1 more source

Optimum level of NEDD4 and its interaction with nsP3 are crucial to facilitate efficient Chikungunya virus (CHIKV) infection. [PDF]

J Gen Virol
Verma S, Chatterjee S, Keshry SS, Dhal AK, Bhowmick B, Newar J, Chattopadhyay S, Ghatak A.   +7 more
europepmc   +1 more source

Redundant and distinct mechanisms suppress innate immune activation during SARS-CoV-2 infection. [PDF]

PLoS Biol
Zhou F, Periasamy S, Jackson ND, Cheng WS, Soto Acosta R, Tripathi A, Kedarinath K, Ilinykh PA, Ye C, Chauhan S, Nudelman G, Zaslavsky E, Hao H, Widen SG, Martinez-Sobrido L, Sealfon SC, Bukreyev A.   +16 more
europepmc   +1 more source